CSO Anders Sandberg interviewed in BioStock on the development in Alzheimer's research
Alzinova AB (publ) ("Alzinova" or the "Company") announces today that Chief Scientific Officer (CSO) Anders Sandberg is interviewed in a recent article in BioStock where he shares his scientific reflections on the latest developments in the industry.Anders Sandberg, Chief Scientific Officer at Alzinova with many years of experience in protein research with an emphasis on neurotoxic peptide aggregates, is Alzinova's CSO and co-founder of the Company. BioStock contacted Sandberg to learn more about how new research findings are impacting the success of Alzheimer's research and what sets